论文部分内容阅读
背景:静脉应用氨茶碱是慢性阻塞性肺疾病(COPD)急性加重期的一种常规治疗方法,但目前却没有足够的证据来证实它的有效性以及中毒的风险。我们首先假定在常规治疗中加用静脉内氨茶碱不会改变肺功能及症状的恢复速度,也不会缩短COPD加重期的住院时间。方法:选择COPD急性加重期未?
BACKGROUND: Intravenous aminophylline is a common treatment for acute exacerbations of chronic obstructive pulmonary disease (COPD), but at present there is insufficient evidence to confirm its effectiveness and risk of poisoning. We first assume that the addition of intravenous aminophylline to conventional therapies does not change the rate of recovery of lung function and symptoms nor does it reduce hospital stays during exacerbations of COPD. Methods: Select COPD acute exacerbation?